TABLE 2.

Hemodynamic and morphologic comparisons between (1) patients with and without adverse outcomes (2) rapid v. slow aortic growth.

Overall cohort
Indexed parameter (per mm)	No adverse outcome (n = 39)	Adverse outcome (n = 12)	P-value	P-value (MV)	Rapid aortic growth (n = 10)	Slow aortic growth (n = 32)	P-value
FL mean reverse flow (mL/cycle)	3.13E-4 ± 1.46E-4	2.21E-4 ± 9.44E-5	0.02*	–	2.37E-4 ± 1.36E-4	2.98E-4 ± 1.46E-4	0.09
FL mean stasis (%)	1.55 ± 0.46	1.16 ± 0.36	0.01*	0.046*	1.39 ± 0.36	1.46 ± 0.46	0.59
TL mean KE (mJ)	2.82E-5 ± 1.38E-5	1.86E-5 ± 1.03E-5	0.02*	–	2.29E-5 ± 1.06E-5	2.75E-5 ± 1.48E-5	0.46
TL mean forward flow (mL/cycle)	2.76E-3 ± 9.57E-4	2.04E-3 ± 7.09E-4	0.01*	–	2.29E-3 ± 8.61E-4	2.63E-3 ± 8.68E-4	0.43
TL peak velocity (cm/s)	5.70 ± 2.05	3.84 ± 1.37	0.01*	0.03*	4.75 ± 1.61	5.45 ± 2.22	0.61
Baseline diameter (mm)	41.97 ± 7.33	50.50 ± 6.87	0.001*	–	45.90 ± 6.12	43.25 ± 8.00	0.28
Entry tear diameter (mm)	7.59 ± 8.25	11.00 ± 3.69	0.004*	–	8.50 ± 4.99	7.13 ± 6.94	0.32
FL diameter (mm)	38.33 ± 8.50	46.17 ± 6.77	0.003*	–	41.50 ± 4.93	39.56 ± 7.81	0.47
KER	3.11E-3 ± 2.34E-3	3.93E-3 ± 2.85E-3	0.41	–	4.23E-3 ± 2.04E-3	3.02E-3 ± 2.34E-3	0.03*

These groupwise comparisons are explored in the overall cohort. Statistically significant differences are highlighted in bold. *P < 0.05. P-value (MV) = p-value derived from multivariate binary logistic regression.